|
||
Title: Reference list 2,(Ergotamine and others) Post by bluebrain on May 15th, 2007, 4:58am 19.- Indoleamines, the role of serotonin in clinical disorders, Heninger et al, Neuropsychopharmacology, 2000 20.- Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Silberstein, Headache,2003 21.- Research into psilocybin and LSD as cluster headache treatment. MAPS, 2004 22.- 5-HT-moduline: a novel endogenous peptide involved in the control of anxiety. Grimaldi, Neuroscience 1999 23.-Clinical effects of serotonin, General practice notebook. 2005 24.- Response of cluster headache to psilocybin and LSD. Sewell RA, Neurology 2006 25.- Effects of 5-HT 1B/1D receptor agonist rizatriptan on cerebral flow and blood volume in normal circulation. Hidehiko Okazawa, J of cerebral blood flow and metabolism, 2006 26.- Anatomy Atlases. www.anatomyatlases.org 27.- Anatomy of the human body, Gray, 1918 28.- Evaluation of the extension of the cerebral blood flow and its main parameters, Gersten,Ben-Gurion University, Israel. 29.- Psychedelic tryptamine carriers. Wikipedia encyclopedia 30.- Cluster headache, www. Clusterheadaches.com 31.- Anterior Cingulate and subgenual prefrontal blood flow changes following tryptophan depletion in healthy males. Neuropsychopharmacology, 2006 32.- Autoradiographic distribution os serotonin transporters and receptor subtypes in human brain. Varnaes K. Human brain mapping, 2004. |
||
Title: Re: Reference list 3,(Ergotamine and others) Post by bluebrain on May 15th, 2007, 5:47am 33.- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Griffiths RR. Psychopharmacology, 2006 34.- Psychedelics could treat addiction ... www.thetyee.ca, 2006 35.- Risk assesment report relating to paddos(psilocin and psilocybin). The DUTCH GOV. The Hague 2000 36.- Hallucinogenic treatment of neurovascular headaches. www.Clusterbusters.com 37.- Synapses. www.users.rcn.com 38.- Migraines and serotonin receptors. Society for neuroscience, 2005 39.- Respuesta de la cefalea en racimos cronica a la psilocibina. REV NEUROL, 2006 Spanish version 40.- Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Carter OL. University of Queensland, Australia, (Neuropsychopharmacology 2005) 41.- Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology 2004 42.- The crucial role of neuronal plasticity in pain and cell death. Corasanti MT. Cell death and differentiation, 2006 43.- Scientists test hallucinogens for mental ills. Blakeslee S, The New York Times. 44.- Cluster headache treatment with Psilocybin mushrooms and LSD. www.erowid.org 45.- DMT and psilocybin research. www.erowid.org 46.- Non-steroidal anti-inflammatory drugs for cancer prevention, Nature reviews, 2006 |
||
Title: Re: Reference list 2,(Ergotamine and others) Post by bluebrain on May 15th, 2007, 7:09am 47.- Cephalalgia, Edited by Goadsby P. www.blackwellpublishing.com, 2004 48.- SB-236057-A: a selective 5-HT1B receptor inverse agonist. Roberts C. CNS Drug Rev 2001 49.- The role and therapeutic potential of 5-HT-moduline in psychiatry. Moret C, Semin Clin Neuropsychiatry 2003 50.- Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Scearce-Levie K. Psychopharmacology 1999 51.- The serotonin transporter: a primary target for antidepressant drugs. Schloss P. J Psychopharmacology 1998 52.- Cluster headache. Dr. B. Ekbal, Headache. (book) 53.- Serotonin catabolism. www.mrel.beckman.uiuc.edu 54.- The neurotransmitter collection. www.microscopy.fsu.edu 55.- Psilocin. Heffter Research institute. www.heffter.org 56.- Controlled capillaries. MacVicar B. Nature/neuroscience. 57.- Dropping acid may help headaches. Arran Frood, Nature 2006 58.- Bidirectional control of CNS capillary diameter by pericytes. Pepiatt C. Nature vol 443/12 2006 59.- Human food preferences are associated with a 5HT2A receptor polymorphism. Prado-Lima PS, Molecular psychiatry 2006 60.- A large-scale study on relationship between cerebral blood flow velocity and blood pressure in a natural population. Zhang P. J of Human Hypertension 2006 61.-Effects of tryptophan depletion on the performance of an iterated prisoner's dilemma game in healthy adults. Wood RM. Neuropsychopharmacology, 2006 62.- Can medication overuse headache be treated by abrupt withdrawal of the overused agent. Relja G. Cephalalgia 2006 63.- Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to Verapamil, Langaee TY. Nature vol 81. 2007 64.- Oral rizatriptan-an effective migraine therapy in pediatric patients? Evers S. Nature/clinical practice/neurology 2007 65.- Clusterbusters, Arran Frood, Nature News vol 13 number1, 2007 |
||
Title: Re: Reference list 2,(Ergotamine and others) Post by bluebrain on May 15th, 2007, 8:27am 66.- 5-HT receptors blockade reduces reward attenuation. Benaliouad. Neuropsychopharmacology. 2007 67.- A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T-cells. O'Connel et al. Blood/ American Society of Hematology. 2005 68.- Psychedelics Encyclopedia, P Stafford, (book) 69.- Melatonin, J Russel et al. (book) 70.- Oxford handbook of clinical medicine, RA Hope, (book) 71.- Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade, De Groote L. Psychopharmacology 2003 72.- SANDOZ and HOFMANN A. Patent database. www.espacenet.com 73.- 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats. Wang H-L. Acta Pharmaco. 2001 74.- Methysergide maleate. Sansert. Novartis/Sandoz. 75.- Cluster headache help 2005. www.chhelp.org 76.- Anita's experiment with Kudzu, www.chhelp.org 77.- The Serotonin club. www.serotoninclub.org 78.- Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Jones M. Neuropsychopharmacology 2005 79.- Ecstasy and serotonin 5-HT1B receptors. EUR J Neuroscience 2003 That will be all, best wishes Bluebrain |
||
Title: Re: Reference list 2,(Ergotamine and others) Post by Lotus on May 16th, 2007, 4:31am This is great , thanks a lot Bluebrain. Here to the reading room ... |
||
Title: Re: Reference list 2,(Ergotamine and others) Post by cluster on May 16th, 2007, 5:46am Hello Bluebrain, thanks a lot! I copied your theory and the refs: http://www.ck-wissen.de/ckwiki/index.php?title=Bluebrain_Theory and started to add a couple of links. (If you want me do delete the "mirror", please let me know.) An advantage of the MediaWiki Software is that everybody can edit the text now. Just click on the "[bearbeiten]" (=edit) button at the right side of the screen on the chapters with the references and the text will be open for editing. (The CK-Wissen website is in German language). If you have a Pubmed ID for the abstract, all you have to add is the "PMID 123456" and the MediaWiki software will generate the link automatically. The syntax for other weblinks is: http://mediawiki.org [http://mediawiki.org] gives [1] [http://mediawiki.org Mediawiki] gives "Mediawiki" If you want to do some testing before you start editing the page linked to above, please use this page: http://www.ck-wissen.de/ckwiki/index.php?title=CK-Wissen:Spielwiese When you have done your edits, click the buttons at the bottom of the page: "Vorschau zeigen" = Preview "Artikel speicherm" = Save A full English language documention for the wiki-syntax is here: http://en.wikipedia.org/wiki/Wikipedia:Help Have fun! Friedrich |
||
Title: Re: Reference list 2,(Ergotamine and others) Post by bluebrain on May 22nd, 2007, 8:43am Hey Friedrich, Thank you for your interest and help. Best wishes Bluebrain |
||
Clusterheadaches.com Message Board » Powered by YaBB 1 Gold - SP 1.3.1! YaBB © 2000-2003. All Rights Reserved. |